Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200041, China.
Reprod Biol Endocrinol. 2023 Apr 26;21(1):40. doi: 10.1186/s12958-023-01089-3.
Studies have shown that sperm-borne microRNAs (miRNAs) are involved in mammalian preimplantation embryonic development. In humans, spermatozoan miR-34c levels are correlated with in vitro fertilization outcomes, such as embryo quality and the clinical pregnancy and live birth rates. In rabbits and cows, miR-34c improves the developmental competence of embryos generated by somatic cell nuclear transfer. However, the mechanisms underlying the regulation of embryonic development by miR-34c remain unknown.
Female C57BL/6 mice (6-8 weeks old) were superovulated, and pronucleated zygotes were collected and microinjected with an miR-34c inhibitor or a negative-control RNA. The embryonic development of the microinjected zygotes was evaluated, and the messenger RNA (mRNA) expression profiles of the embryos at the two-cell, four-cell and blastocyst stages (five embryos per group) were determined by RNA sequencing analysis. Gene expression levels were verified by reverse transcription-quantitative polymerase chain reaction. Cluster analysis and heat map visualization were performed to detect differentially expressed mRNAs. Pathway and process enrichment analyses were performed using ontology resources. Differentially expressed mRNAs were systematically analyzed using the Search Tool for the Retrieval of Interacting Genes/Proteins database to determine their biological functions.
Embryonic developmental potential was significantly reduced in zygotes microinjected with the miR-34c inhibitor compared with those microinjected with a negative-control RNA. Two-cell stage embryos microinjected with an miR-34c inhibitor presented altered transcriptomic profiles, with upregulated expression of maternal miR-34c target mRNAs and classical maternal mRNAs. Differentially expressed transcripts were mainly of genes associated with lipid metabolism and cellular membrane function at the two-cell stage, with cell-cycle phase transition and energy metabolism at the four-cell stage; and with vesicle organization, lipid biosynthetic process and endomembrane system organization at the blastocyst stage. We also showed that genes related to preimplantation embryonic development, including Alkbh4, Sp1, Mapk14, Sin3a, Sdc1 and Laptm4b, were significantly downregulated after microinjection of an miR-34c inhibitor.
Sperm-borne miR-34c may regulate preimplantation embryonic development by affecting multiple biological processes, such as maternal mRNA degradation, cellular metabolism, cell proliferation and blastocyst implantation. Our data demonstrate the importance of sperm-derived miRNAs in the development of preimplantation embryos.
研究表明,精子携带的 microRNAs(miRNAs)参与了哺乳动物的着床前胚胎发育。在人类中,精子 miR-34c 的水平与体外受精结局相关,如胚胎质量、临床妊娠率和活产率。在兔子和奶牛中,miR-34c 提高了体细胞核移植产生的胚胎的发育能力。然而,miR-34c 调控胚胎发育的机制尚不清楚。
对 6-8 周龄的 C57BL/6 雌性小鼠进行超数排卵,收集原核期受精卵并进行 miR-34c 抑制剂或阴性对照 RNA 的显微注射。评估显微注射受精卵的胚胎发育情况,并通过 RNA 测序分析检测两细胞、四细胞和囊胚期(每组 5 个胚胎)胚胎的信使 RNA(mRNA)表达谱。通过逆转录定量聚合酶链反应验证基因表达水平。采用聚类分析和热图可视化方法检测差异表达的 mRNA。利用本体资源进行通路和过程富集分析。使用搜索工具检索相互作用基因/蛋白数据库系统地分析差异表达的 mRNA,以确定其生物学功能。
与阴性对照 RNA 显微注射的受精卵相比,miR-34c 抑制剂显微注射的受精卵的胚胎发育潜能显著降低。miR-34c 抑制剂显微注射的两细胞期胚胎呈现出改变的转录组谱,母源 miR-34c 靶标 mRNA 和经典母源 mRNA 的表达上调。差异表达的转录本主要与两细胞期的脂质代谢和细胞膜功能相关的基因有关,在四细胞期与细胞周期阶段过渡和能量代谢相关,在囊胚期与囊泡组织、脂质生物合成过程和内细胞膜系统组织相关。我们还表明,与植入前胚胎发育相关的基因,包括 Alkbh4、Sp1、Mapk14、Sin3a、Sdc1 和 Laptm4b,在 miR-34c 抑制剂显微注射后显著下调。
精子携带的 miR-34c 可能通过影响母体 mRNA 降解、细胞代谢、细胞增殖和囊胚着床等多个生物学过程来调节着床前胚胎发育。我们的数据证明了精子来源的 miRNAs 在着床前胚胎发育中的重要性。